← Back to Search

Procedure

Treatment for Heart Failure

N/A
Waitlist Available
Research Sponsored by Ancora Heart, Inc.
Eligibility Criteria Checklist
Specific guidelines that determine who can or cannot participate in a clinical trial
Must have
Be older than 18 years old
Timeline
Screening 3 weeks
Treatment Varies
Follow Up 30-day
Awards & highlights

Summary

This is prospective, non-randomized, single-arm, international, multicenter, clinical safety and performance clinical investigation to evaluate the AccuCinch® Ventricular Repair System for the treatment of heart failure, with or without functional mitral regurgitation due to dilated ischemic or non-ischemic cardiomyopathy

Eligible Conditions
  • Heart Failure
  • Cardiomyopathy

Timeline

Screening ~ 3 weeks
Treatment ~ Varies
Follow Up ~30-day
This trial's timeline: 3 weeks for screening, Varies for treatment, and 30-day for reporting.

Treatment Details

Study Objectives

Study objectives can provide a clearer picture of what you can expect from a treatment.
Primary study objectives
Safety outcome: 30-day major adverse events (MAEs)
Secondary study objectives
Clinical outcome: Freedom from re-hospitalizations or re-interventions for the underlying condition
Clinical outcome: Improvement in Kansas City Cardiomyopathy Questionnaire (KCCQ) Quality of Life (QoL)
Clinical outcome: Improvement in NYHA functional class
+3 more

Find a Location

Who is running the clinical trial?

Ancora Heart, Inc.Lead Sponsor
8 Previous Clinical Trials
488 Total Patients Enrolled
6 Trials studying Heart Failure
464 Patients Enrolled for Heart Failure
Michael Zapien, MS, CCRAStudy DirectorAncora Heart, Inc.
3 Previous Clinical Trials
62 Total Patients Enrolled
3 Trials studying Heart Failure
62 Patients Enrolled for Heart Failure
~20 spots leftby Sep 2025
Unbiased ResultsWe believe in providing patients with all the options.
Your Data Stays Your DataWe only share your information with the clinical trials you're trying to access.
Verified Trials OnlyAll of our trials are run by licensed doctors, researchers, and healthcare companies.
Back to top